S.C. Terapia S.A. Sustainability Profile
S.C. Terapia S.A., a prominent player in the Romanian healthcare sector, is headquartered in Romania and operates extensively across various regions. Founded in 1992, the company has established itself as a leader in the pharmaceutical industry, focusing on the development and distribution of innovative therapeutic solutions. With a diverse portfolio that includes prescription medications, over-the-counter products, and dietary supplements, S.C. Terapia S.A. is renowned for its commitment to quality and efficacy. The company’s unique approach to research and development has led to several key milestones, solidifying its market position as a trusted provider of healthcare solutions. Recognised for its contributions to patient care, S.C. Terapia S.A. continues to advance its mission of improving health outcomes through cutting-edge products and services tailored to meet the needs of healthcare professionals and patients alike.
DitchCarbon Score
How does S.C. Terapia S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
S.C. Terapia S.A.'s score of 64 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
S.C. Terapia S.A., headquartered in Romania, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Sun Pharmaceutical Industries Limited, which may influence its climate commitments and reporting practices. While S.C. Terapia S.A. has not established specific reduction targets or initiatives, it is important to note that it inherits its climate performance metrics from its parent company, Sun Pharmaceutical Industries Limited. This relationship suggests that any climate commitments or emissions data may be aligned with the broader sustainability goals set by Sun Pharmaceutical Industries. As of now, S.C. Terapia S.A. has not publicly committed to any specific climate pledges or initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). The lack of detailed emissions data and reduction targets indicates that the company may still be in the early stages of developing a comprehensive climate strategy. In summary, S.C. Terapia S.A. currently lacks specific emissions data and reduction commitments, relying on the corporate sustainability framework of its parent company, Sun Pharmaceutical Industries Limited, for guidance on climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 77,616,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 377,728,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 |
How Carbon Intensive is S.C. Terapia S.A.'s Industry?
How Carbon Intensive is S.C. Terapia S.A.'s Location?
S.C. Terapia S.A.'s Scope 3 Categories Breakdown
S.C. Terapia S.A.'s Scope 3 emissions, which increased by 6% last year and increased by approximately 6% since 2023, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 51% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 62% of Scope 3 emissions.
Top Scope 3 Categories
S.C. Terapia S.A.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
S.C. Terapia S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
